<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03864588</url>
  </required_header>
  <id_info>
    <org_study_id>2018LonnerSS</org_study_id>
    <nct_id>NCT03864588</nct_id>
  </id_info>
  <brief_title>Comparing Ropivacaine Adductor Canal Blockade by Surgeon Versus Anesthesiologist</brief_title>
  <official_title>A Randomized Controlled Trial Comparing Intraoperative Surgeon-Performed Versus Anesthesiologist-Performed Adductor Canal Blockade After Primary Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rothman Institute Orthopaedics</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sharpe-Strumia Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rothman Institute Orthopaedics</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of two methods of administering an
      adductor canal block (ACB) following total knee arthroplasty (TKA); intraoperative surgeon
      performed intra-articular adductor canal block (IACB) and anesthesiologist ultrasound guided
      ADC in the post-anesthesia recovery unit (PACU).
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in visual analog scale pain score</measure>
    <time_frame>Up to 6 weeks post-surgery</time_frame>
    <description>The primary end point is the patients' reported visual analogue pain score (VAS). 0-100mm scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in range of motion</measure>
    <time_frame>up to 6 weeks post-surgery</time_frame>
    <description>Range of motion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in timed up and go</measure>
    <time_frame>up to 6 weeks post-surgery</time_frame>
    <description>Timed up and go</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in daily opioid consumption</measure>
    <time_frame>up to 6 weeks post-surgery</time_frame>
    <description>daily opioid consumption</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">164</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Satisfaction</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Anesthesiologist preforms ultrasound guided adductor canal block post-operatively</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Surgeon preforms inter-operative adductor canal block</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>For primary TKA, Ropivacaine is used in both arms, either performed intra-operatively by surgeon or post-operatively (ultrasound guided) by anesthesiologist.</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing unilateral primary TKA with underlying diagnosis of osteoarthritis

          -  ASA I - III

          -  Spinal anesthesia

          -  All patients will have cemented total knee utilizing a medial parapatellar approach
             with posterior stabilized or cruciate retaining implants. A tourniquet will be used in
             all cases.

          -  Patients must be between 18 and 80 years of age.

          -  Active and valid email address for the participant.

        Exclusion Criteria:

          -  Allergy to anesthetics or study analgesic medications.

          -  Contraindication to regional anesthesia

          -  Non-english speaking

          -  ASA IV or greater

          -  Renal insufficiency with Cr &gt; 2.0 or hepatic failure

          -  General or epidural anesthesia

          -  Sensory/motor disorder involving the operative limb

          -  Patients who consume preoperative opioids for pain control.

          -  Pregnant women

          -  Mentally disabled patients and patients with psychiatric disorders that would prevent
             them from properly understanding and evaluating an informed consent process.

          -  Prisoners
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rothman Institute</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>October 26, 2018</study_first_submitted>
  <study_first_submitted_qc>March 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 6, 2019</study_first_posted>
  <last_update_submitted>March 4, 2019</last_update_submitted>
  <last_update_submitted_qc>March 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

